Literature DB >> 11756173

Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor.

Scott G Kitchen1, Stuart LaForge, Viresh P Patel, Christina M Kitchen, M Carrie Miceli, Jerome A Zack.   

Abstract

It was previously shown that costimulation of CD8(+) lymphocytes results in de novo expression of CD4. This study expanded on this observation to investigate the function of CD4 on CD8 cells. The ability of costimulated CD8 cells to respond to interleukin 16 (IL-16), a ligand that binds CD4 and induces cellular chemotaxis, was examined. IL-16-mediated ligation of CD4 expressed on CD8 T cells was found to induce an intracellular signal that directs migration of these cells in vitro. Thus, expression of CD4 on a CD8 lymphocyte has functional importance and may serve to control distribution of newly activated CD8 T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756173     DOI: 10.1182/blood.v99.1.207

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface.

Authors:  Andrew Zloza; Jason M Schenkel; Allan R Tenorio; Jeffrey A Martinson; Paul M Jeziorczak; Lena Al-Harthi
Journal:  Blood       Date:  2009-08-21       Impact factor: 22.113

2.  Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

Authors:  Jeffrey M Milush; Brian R Long; Jennifer E Snyder-Cappione; Amedeo J Cappione; Vanessa A York; Lishomwa C Ndhlovu; Lewis L Lanier; Jakob Michaëlsson; Douglas F Nixon
Journal:  Blood       Date:  2009-10-05       Impact factor: 22.113

3.  Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model.

Authors:  Christopher R Gilson; James C Zimring
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

4.  The Chemokine Receptor CXCR3 Promotes CD8+ T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection.

Authors:  Sofia Caldeira-Dantas; Thomas Furmanak; Corinne Smith; Michael Quinn; Leyla Y Teos; Adam Ertel; Drishya Kurup; Mayank Tandon; Ilias Alevizos; Christopher M Snyder
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

Review 5.  Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.

Authors:  James L Riley; Luis J Montaner
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

6.  The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens.

Authors:  Scott G Kitchen; Jason K Whitmire; Nicole R Jones; Zoran Galic; Christina M R Kitchen; Rafi Ahmed; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-24       Impact factor: 11.205

7.  Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.

Authors:  John Scholler; Troy L Brady; Gwendolyn Binder-Scholl; Wei-Ting Hwang; Gabriela Plesa; Kristen M Hege; Ashley N Vogel; Michael Kalos; James L Riley; Steven G Deeks; Ronald T Mitsuyasu; Wendy B Bernstein; Naomi E Aronson; Bruce L Levine; Frederic D Bushman; Carl H June
Journal:  Sci Transl Med       Date:  2012-05-02       Impact factor: 17.956

8.  HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells.

Authors:  Anjie Zhen; Masakazu Kamata; Valerie Rezek; Jonathan Rick; Bernard Levin; Saro Kasparian; Irvin Sy Chen; Otto O Yang; Jerome A Zack; Scott G Kitchen
Journal:  Mol Ther       Date:  2015-06-08       Impact factor: 11.454

9.  High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.

Authors:  Alexandra Cochrane; Stuart Imlach; Clifford Leen; Gordon Scott; Dermot Kennedy; Peter Simmonds
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection.

Authors:  Scott G Kitchen; Nicole R Jones; Stuart LaForge; Jason K Whitmire; Bien-Aimee Vu; Zoran Galic; David G Brooks; Stephen J Brown; Christina M R Kitchen; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.